Nonsteroidal Anti-inflammatory Drug Market
Nonsteroidal Anti-inflammatory Drug Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Nonsteroidal Anti-inflammatory Drug Market Size and Growth
The Nonsteroidal Anti-inflammatory Drug (NSAID) market is experiencing steady growth, driven by rising chronic pain prevalence and increasing geriatrics. The global market is projected to reach approximately USD 30 billion by 2025, influenced by innovations in formulations and a shift towards overthe-counter sales, despite increasing regulatory scrutiny and competition. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bayer
◍ Actavis
◍ Teva
◍ Mylan
◍ Pfizer
◍ Novartis
◍ Horizon Pharma
◍ Iroko Pharmaceuticals
◍ Hoechst
◍ Xinhua Pharm
The Nonsteroidal Anti-inflammatory Drug (NSAID) market features Bayer, Actavis, Teva, Mylan, Pfizer, Novartis, Horizon Pharma, Iroko Pharmaceuticals, Hoechst, and Xinhua Pharm. These companies enhance market growth through innovative formulations, extensive distribution networks, and strategic partnerships, impacting sales positively. Some sales figures include:
- Bayer: $47 billion
- Pfizer: $41 billion
- Novartis: $52 billion
Request Sample Report
Market Segmentation
By Application
Application I
Application II
Request Sample Report
By Product
Type I
Type II
Market Growth
Request Sample Report
$ X Billion USD
